9 results  1 of 1 

1 Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study
Ramit Mahajan, Arshdeep Singh, Saurabh Kedia, Kirandeep Kaur, Vandana Midha, Pabitra Sahu, Varun Mehta, Dharmatma Singh, Namita Bansal, Khushdeep Dharni, Sandeep Kaushal, Vineet Ahuja, Ajit Sood
Intest Res.2022;20(1):64-71.   Published online 2021 February 3     DOI: http://dx.doi.org/10.5217/ir.2020.00100
      
2 Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
Ajit Sood, Vineet Ahuja, Vandana Midha, Saroj Kant Sinha, C. Ganesh Pai, Saurabh Kedia, Varun Mehta, Sawan Bopanna, Philip Abraham, Rupa Banerjee, Shobna Bhatia, Karmabir Chakravartty, Sunil Dadhich, Devendra Desai, Manisha Dwivedi, Bhabhadev Goswami, Kirandeep Kaur, Rajeev Khosla, Ajay Kumar, Ramit Mahajan, S. P. Misra, Kiran Peddi, Shivaram Prasad Singh, Arshdeep Singh
Intest Res.2020;18(4):355-378.   Published online 2020 July 13     DOI: http://dx.doi.org/10.5217/ir.2019.09176
      
3 Recurrent Eosinophilic Pneumonia Associated with Mesalazine Suppository in a Patient with Ulcerative Colitis
Myoungrin Park, Junguee Lee, Sang-Bum Kang, Yeonhee Park
Korean J Gastroenterol.2019;73(4):225-229.   Published online 2019 April 26     DOI: http://dx.doi.org/10.4166/kjg.2019.73.4.225
      
4 Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
Soo-Kyung Park, Sang Hyun Park, Chang Soo Eun, Geom Seog Seo, Jong Pil Im, Tae Oh Kim, Dong-Il Park
Intest Res.2019;17(3):349-356.   Published online 2019 February 8     DOI: http://dx.doi.org/10.5217/ir.2018.00064
      
5 Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients
Keiji Yagisawa, Taku Kobayashi, Ryo Ozaki, Shinji Okabayashi, Takahiko Toyonaga, Miki Miura, Mari Hayashida, Eiko Saito, Masaru Nakano, Hajime Matsubara, Tadakazu Hisamatsu, Toshifumi Hibi
Intest Res.2019;17(1):87-93.   Published online 2018 December 14     DOI: http://dx.doi.org/10.5217/ir.2018.00078
      
6 Evaluation of the drug-induced lymphocyte stimulation test for diagnosing mesalazine allergy
Daisuke Saito, Mari Hayashida, Taro Sato, Shintaro Minowa, Osamu Ikezaki, Tatsuya Mitsui, Miki Miura, Akihito Sakuraba, Tadakazu Hisamatsu
Intest Res.2018;16(2):273-281.   Published online 2018 April 30     DOI: http://dx.doi.org/10.5217/ir.2018.16.2.273
      
7 Drug-induced eosinophilic pneumonia in a patient with Crohn's disease: diagnosis and treatment using fraction of exhaled nitric oxide
Jina Yeo, Hyun Sun Woo, Sang Min Lee, Yoon Jae Kim, Kwang An Kwon, Dong Kyun Park, Jung Ho Kim, Kyoung Oh Kim, Jun-Won Chung
Intest Res.2017;15(4):529-534.   Published online 2017 October 23     DOI: http://dx.doi.org/10.5217/ir.2017.15.4.529
      
8 Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter, randomized, double-blind, parallel-group study
Yasuo Suzuki, Mitsuo Iida, Hiroaki Ito, Isamu Saida, Toshifumi Hibi
Intest Res.2016;14(1):50-59.   Published online 2016 January 26     DOI: http://dx.doi.org/10.5217/ir.2016.14.1.50
      
9 Acute Pancreatitis Induced by Azathioprine and 6-mercaptopurine Proven by Single and Low Dose Challenge Testing in a Child with Crohn Disease
Geum-Chae-Won Yi, Ka-Hyun Yoon, Jin-Bok Hwang
Pediatr Gastroenterol Hepatol Nutr.2012;15(4):272-275.   Published online 2012 December 31     DOI: http://dx.doi.org/10.5223/pghn.2012.15.4.272
      

 1 of 1